FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method for producing a polymer conjugate of isonicotinic acid hydrazone applied as an anti-tuberculosis drug. The specified method consists in preparing 6-13 wt % pre-purified low-molecular chitosan in aqueous acetic acid with added 40% aqueous formaldehyde. The system is dispersed for 30 minutes at 25°C and for 60 minutes at 70°C. Further, the system is added with 1.5 mole chitosan-related isonicotinic acid hydrazide and acetyl chloride in a catalytic amount. The mixture is mixed and heated at 70°C for 5 hours. The prepared reaction mass is treated under vacuum; a solid residue is extracted in ethanol and dried.
EFFECT: higher drug adsorption in macrophages and its biodegradability.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO PRODUCE WATER-SOLUBLE OLIGOMER HOMOLOGS OF CHITOSANS IN HETEROGENEOUS SYSTEM | 2011 |
|
RU2479590C1 |
| PHARMACOLOGICAL AGENT POSSESSING ANTITUBERCULOSIS ACTIVITY | 2011 |
|
RU2469711C1 |
| SUBSTITUTED DI-(FORMYLARYL)-POLYESTERS OR THEIR COORDINATION COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION ON SAID | 1998 |
|
RU2137750C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF BIOICIDAL NITROGEN CONTAINING ORGANIC COMPOUND OF ISONICOTINIC ACID HYDRAZID (IZONIAZID) IN WATER SOLUTION OF THIS COMPOUND | 2016 |
|
RU2633080C2 |
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
| METHOD FOR LIMITATION OF COMPLICATIONS AND ADVERSE SYMPTOMS IN TREATMENT OF TUBERCULOSIS | 2001 |
|
RU2217137C2 |
| METHOD FOR PRODUCING POLYMERIC COMPLEX | 2010 |
|
RU2435611C1 |
| METHOD FOR PREPARING WATER-SOLUBLE CHITOSAN PARA-AMINOSALICYLATE | 2010 |
|
RU2440111C1 |
| DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
| DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
